Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?
Keywords:Congenital mesoblastic nephroma, Recurrence, Adjuvant therapy, Neonate
AbstractCongenital mesoblastic nephroma (CMN) is a rare renal tumor of infancy. Complete surgical excision is often sufficient. A premature neonate underwent left radical nephrectomy for CMN without any adjuvant therapy. Pathology was consistent with cellular type CMN. Six months postoperatively, the patient developed recurrence. He subsequently underwent re-excision without any adjuvant chemotherapy. The baby is tumor free for more than a year.
Download data is not yet available.
Metrics Loading ...
How to Cite
Nahla K, Dorsaf M, Samia B, Nahla H, Rachida L, Mongi M, Mohssen B, Abdellatif N. Congenital Mesoblastic Nephroma in a Premature Neonate: Should We Give Adjuvant Chemotherapy?. J Neonatal Surg [Internet]. 2019Dec.27 [cited 2021Mar.1];8(3):22. Available from: https://jneonatalsurg.com/ojs/index.php/jns/article/view/242
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.